Roivant Sciences ROIV
NASDAQ ROIV
$35.50 -1.07 (-2.93%)
At close: Oct 1, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Cash from Financing Activities (2020 - 2026)

Updated

Roivant Sciences (ROIV) recorded Cash from Financing Activities of -$181.51 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$187.77 million a year earlier.

Analysis

Roivant Sciences (ROIV) Cash from Financing Activities (2020 - 2026) Analysis & Trends

On a TTM basis, Roivant Sciences' Cash from Financing Activities came in at $140.49 million as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it was $134.24 million.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -21.7% (FY2021 to FY2026).
  • Across earlier fiscal years, Cash from Financing Activities came in at -$1.22 billion in FY2025, $419.36 million in FY2024 (-16.0%), $499.46 million in FY2023 (+62.8%) and $306.79 million in FY2022 (-32.8%).
  • Quarterly Cash from Financing Activities has ranged from -$660.62 million in fiscal Q1 2025 to $328.19 million in fiscal Q3 2026 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at -$68.78 million (Q4 2026), $328.19 million (Q3 2026) and $62.59 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Roivant Sciences 26.43 Bn 27.12 Bn 1.16 Mn -181.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -181.51 Mn
Mar 31, 2026 -68.78 Mn
Dec 31, 2025 328.19 Mn
Sep 30, 2025 62.59 Mn
Jun 30, 2025 -187.77 Mn
Mar 31, 2025 -177.15 Mn
Dec 31, 2024 -272.95 Mn
Sep 30, 2024 -109.07 Mn
Jun 30, 2024 -660.62 Mn
Mar 31, 2024 -32.62 Mn
Dec 31, 2023 236.64 Mn
Sep 30, 2023 207.87 Mn
Jun 30, 2023 7.48 Mn
Mar 31, 2023 210.33 Mn
Dec 31, 2022 154.50 Mn
Sep 30, 2022 -7.34 Mn
Jun 30, 2022 141.98 Mn
Mar 31, 2022 1.07 Mn
Dec 31, 2021 -8.42 Mn
Sep 30, 2021 303.93 Mn
API Access

Roivant Sciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ROIV&period=max&api_key=YOUR_API_KEY